SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

Left Sided AngioVAC, ECMO, ViV TMVR, ViV TAVR

University of Miami

J. Barrientos

Therapeutic Hypothermia After Cardiac Arrest

John McPherson

COVID-19 & ICU FAQ Answered: When Should We Intubate & How Do We Adj…

Hassan Bencheqroun MD FCCP

ECG Interpretation: Everything You Need to Know to Understand and In…

Houston Methodist DeBakey Heart and Vascular Center

A. Dave

EHRA 2024: Ongoing Clinical Investigations with Cardiac Contractilit…

CCM® Therapy

N. Varma

EHRA 2024: Real-World Experience with Cardiac Contractility Modulati…

CCM® Therapy

J. Kuschyk

EHRA 2024: Cardiac Contractility Modulation: Innovative Therapy for …

CCM® Therapy

V. Reddy, N. Varma, K. Kuck, J. Kuschyk, N. Aspromonte

PEEP Titration in ARDS Roundtable

PulmPEEPs

D. Furfaro, K. Montemayor, S. Sahetya, T. Rice, E. Baedorf-Kassis, R. Brower

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

EHRA 2024: Unmet Medical Needs in Heart Failure Management: Can Devi…

CCM® Therapy

N. Aspromonte

EHRA 2024: Cardiac Contractility Modulation: Innovation Therapy for …

CCM® Therapy

K. Kuck, J. Kuschyk, V. Reddy, N. Aspromonte, N. Varma

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

Heart Failure Case Presentations

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

B. Greenberg, G. Fonarow, N. Wettersten, M. Rosa Costanzo

Q&A: Organizing ECMO and ECLS for VF Cardiac Arrest

7th Annual Western New England Acute Cardiology Conference

D. Yannopoulos, A. Lotfi